天壇生物(600161.SH)擬籌劃定增募資不超30億元 用於產業化基地項目及補充流動資金等
格隆匯 7 月 23日丨天壇生物(600161.SH)公佈,公司股票在2020年7月21日、7月22日、7月23日連續三個交易日收盤價格漲幅偏離值累計超過20%,根據《上海證券交易所交易規則》的有關規定,屬於股票交易異常波動情形;
經公司自查,公司擬籌劃非公開發行股票事項,擬向不超過35名特定投資者非公開發行股票,募集資金總額預計不超過30億元,主要用於與公司主營業務相關的產業化基地項目及補充流動資金等。此次非公開發行結束後,公司控股股東、實際控制人不會發生變化。
此次非公開發行方案仍在完善中,尚未經公司董事會、股東大會審議,此次發行後續也需獲得中國證監會的核準。上述事項能否獲得相關批準或核准,以及獲得相關批准或核准的時間,均存在不確定性。除此之外,公司不存在其它應披露未披露的重大事項。
目前公司生產經營活動一切正常。後續公司將根據相關規定,對非公開發行股票進展情況持續進行披露。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.